📣 VC round data is live. Check it out!
- Public Comps
- Beiersdorf
Beiersdorf Valuation Multiples
Discover revenue and EBITDA valuation multiples for Beiersdorf and similar public comparables like Essity, Kao, Yunnan Baiyao Group, Church & Dwight and more.
Beiersdorf Overview
About Beiersdorf
Beiersdorf is a Germany-based company that produces personal-care products, with a focus on manufacturing cosmetic products. The company operates through two business segments. The consumer segment provides skincare and beauty care products and operates portfolio brands such as Nivea, Eucerin, La Prairie, Labello, Hansaplast, Elastoplast, and Florena. The other business segment markets self-adhesive system and product solutions, primarily for industrial customers, under the Tesa brand. Beiersdorf is majority-owned by Maxingvest.
Founded
1882
HQ

Employees
22.8K
Website
Sectors
Financials (LTM)
EV
$15B
Valuation Multiples
Start free trialBeiersdorf Financials
Beiersdorf reported last 12-month revenue of $11B and EBITDA of $2B.
In the same LTM period, Beiersdorf generated $7B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
Beiersdorf P&L
In the most recent fiscal year, Beiersdorf reported revenue of $12B and EBITDA of $2B.
Beiersdorf is profitable as of last fiscal year, with gross margin of 58%, EBITDA margin of 17%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Beiersdorf Stock Performance
Beiersdorf has current market cap of $18B, and enterprise value of $15B.
Market Cap Evolution
Beiersdorf's stock price is $82.77.
Beiersdorf share price increased by 0.4% in the last 30 days, and decreased by 40.5% in the last year.
Beiersdorf has an EPS (earnings per share) of $5.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15B | $18B | 0.0% | 0.4% | -34.9% | -40.5% | $5.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBeiersdorf Valuation Multiples
Beiersdorf trades at 1.3x EV/Revenue multiple, and 7.8x EV/EBITDA.
EV / Revenue (LTM)
Beiersdorf Financial Valuation Multiples
As of May 4, 2026, Beiersdorf has market cap of $18B and EV of $15B.
Beiersdorf has a P/E ratio of 16.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Beiersdorf Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Beiersdorf Margins & Growth Rates
Beiersdorf decreased revenue by 0% and EBITDA by 3% in the last fiscal year.
In the most recent fiscal year, Beiersdorf reported gross margin of 58%, EBITDA margin of 17%, and net margin of 10%.
Beiersdorf Margins
Beiersdorf Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Beiersdorf Operational KPIs
Beiersdorf's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Beiersdorf's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Beiersdorf's Rule of X is 16% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Beiersdorf Competitors
Beiersdorf competitors include Essity, Kao, Yunnan Baiyao Group, Church & Dwight, Ulta Beauty, Cooper Companies, Puig Brands, Godrej Consumer Products, APR Co. and Marico.
Most Beiersdorf public comparables operate across Health & Beauty.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.4x | 1.4x | 7.5x | 7.6x | |||
| 1.5x | 1.5x | 10.2x | 9.9x | |||
| 2.0x | 2.0x | 12.6x | 13.6x | |||
| 3.9x | 4.0x | 18.8x | 17.1x | |||
| 2.0x | 2.0x | 13.4x | 13.3x | |||
| 3.6x | 3.5x | 11.3x | 10.9x | |||
| 2.0x | 2.0x | 9.2x | 9.7x | |||
| 6.9x | 7.1x | 32.7x | 34.4x | |||
This data is available for Pro users. Sign up to see all Beiersdorf competitors and their valuation data. Start Free Trial | ||||||
Beiersdorf M&A Activity
Beiersdorf has acquired 3 companies to date.
Last acquisition by Beiersdorf was on December 16th 2022. Beiersdorf acquired S-Biomedic for $645M (EV/Revenue multiple of ).
Latest Acquisitions by Beiersdorf
| Description | S-Biomedic is a UK-based biotech firm engineering microbiome-targeted therapies for skin disorders like acne, eczema, and rosacea. Headquartered in London, the company formulates products using selected beneficial bacteria strains to restore microbial balance, applicable in prescription dermatology and over-the-counter cosmetics through partnerships with contract manufacturers. | Chantecaille is a New York-based luxury beauty brand offering botanical skincare, makeup, and fragrances. The company produces products like Bio Lifting Serum+, Future Skin cushion foundation, and Wild Orchid eye cream using plant extracts without parabens or synthetic dyes. Chantecaille sells through Neiman Marcus, Nordstrom, and its website, supporting wildlife conservation via product sales. | Coppertone is a leading US sunscreen brand owned by Beiersdorf since 2021, offering lotions, sprays, and sticks with SPF levels from 15 to 100+. Its Sport and Water Babies lines protect against UVA/UVB rays during outdoor activities. Coppertone manufactures at facilities in Tennessee and distributes through Walmart, Target, and pharmacies nationwide. Introduced in 1944, the brand holds over 20% US market share in sun care. |
| HQ Country | |||
| HQ City | Milwaukee, WI | New York City, NY | Stamford, CT |
| Deal Date | 16 Dec 2022 | 22 Dec 2021 | 13 May 2019 |
| Valuation | $645M | $690M | $550M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Beiersdorf acquisitions and their M&A valuation multiples. Start Free Trial | |||
Beiersdorf Investment Activity
Beiersdorf has invested in 8 companies to date.
Latest investment by Beiersdorf was on December 8th 2025. Beiersdorf invested in Melt&Marble in their $9M Series A round (EV/Revenue multiple of ).
Latest Investments by Beiersdorf
| Description | Melt&Marble is a precision fermentation company producing animal-free fats for plant-based foods. It engineers microbes to create structured lipids mimicking beef tallow and pork lard, used in burgers and pastries by food manufacturers. Amsterdam-headquartered since 2020, the startup partners with ingredient suppliers to supply fats for hybrid meat products across Europe. | Cellvie is a Basel-based biopharma company engineering mitochondria transplantation therapies to treat ischemia-reperfusion injuries in heart attacks and strokes. Licensing technology from Harvard researchers, their lead candidate CV-1 delivers functional mitochondria via extracellular vesicles to restore cellular energy production. Cellvie conducts preclinical studies in porcine models and collaborates with European clinics for acute cardiovascular applications. | DePoly is a Netherlands-based chemical recycling firm that depolymerizes post-consumer PET plastics and polyester textiles into monomers at ambient temperature. Its patented process eliminates pre-washing, sorting, or separation needs, yielding high-purity terephthalic acid and ethylene glycol for reuse in virgin-quality production. Operating pilot facilities in Amsterdam, DePoly partners with textile brands and plastic converters to scale circular economy solutions, targeting waste from bottles and apparel across Europe. | Vincere Biosciences is a Johnson & Johnson JLABS incubator company developing therapeutics targeting the progression of Parkinson's disease. The San Diego-based biotech focuses on novel drug candidates to address neurodegeneration. | |
| HQ Country | |||||
| HQ City | Göteborg | Houston, TX | Sion | — | |
| Deal Date | 8 Dec 2025 | 9 Sep 2025 | 29 Apr 2025 | 1 Apr 2025 | |
| Round | Series A | Seed | Seed | Series A | |
| Raised | $9M | $5M | $23M | $5M | |
| Investors | Beiersdorf; Catalyze Capital; Chalmers Ventures AB; European Innovation Council Fund; Industrifonden; Valio | Beiersdorf; KIZOO Technology Capital; Taiho Ventures | Angel Invest; BASF Venture Capital; Beiersdorf; Founderful; MassMutual Ventures; Syensqo Ventures; Zürcher Kantonal Bank | Alumni Ventures; Beiersdorf; Beresford Ventures; Daewoong Pharmaceutical; Draper Associates; FreeMind Investments; HanAll Biopharma; Healthspan Capital; Kastor Capital; KreaMedica; LongGame; Michael J. Fox Foundation | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Beiersdorf investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Beiersdorf
| When was Beiersdorf founded? | Beiersdorf was founded in 1882. |
| Where is Beiersdorf headquartered? | Beiersdorf is headquartered in Germany. |
| How many employees does Beiersdorf have? | As of today, Beiersdorf has over 22K employees. |
| Is Beiersdorf publicly listed? | Yes, Beiersdorf is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Beiersdorf? | Beiersdorf trades under BEI ticker. |
| When did Beiersdorf go public? | Beiersdorf went public in 1929. |
| Who are competitors of Beiersdorf? | Beiersdorf main competitors include Essity, Kao, Yunnan Baiyao Group, Church & Dwight, Ulta Beauty, Cooper Companies, Puig Brands, Godrej Consumer Products, APR Co., Marico. |
| What is the current market cap of Beiersdorf? | Beiersdorf's current market cap is $18B. |
| What is the current revenue of Beiersdorf? | Beiersdorf's last 12 months revenue is $11B. |
| What is the current revenue growth of Beiersdorf? | Beiersdorf revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Beiersdorf? | Current revenue multiple of Beiersdorf is 1.3x. |
| Is Beiersdorf profitable? | Yes, Beiersdorf is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Beiersdorf? | Beiersdorf's last 12 months EBITDA is $2B. |
| What is Beiersdorf's EBITDA margin? | Beiersdorf's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Beiersdorf? | Current EBITDA multiple of Beiersdorf is 7.8x. |
| What is the current FCF of Beiersdorf? | Beiersdorf's last 12 months FCF is $634M. |
| What is Beiersdorf's FCF margin? | Beiersdorf's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Beiersdorf? | Current FCF multiple of Beiersdorf is 23.9x. |
| How many companies Beiersdorf has acquired to date? | As of May 2026, Beiersdorf has acquired 3 companies. |
| What was the largest acquisition by Beiersdorf? | $690M acquisition of Chantecaille on 22nd December 2021 was the largest M&A Beiersdorf has done to date. |
| What companies Beiersdorf acquired? | Beiersdorf acquired Chantecaille, S-Biomedic, and Coppertone. |
| In how many companies Beiersdorf has invested to date? | As of May 2026, Beiersdorf has invested in 8 companies. |
| What was the last Beiersdorf investment? | On 8th December 2025 Beiersdorf invested in Melt&Marble, participating in a $9M Series A round, alongside Catalyze Capital, Chalmers Ventures AB, European Innovation Council Fund, Industrifonden, and Valio. |
| In what companies Beiersdorf invested in? | Beiersdorf invested in DePoly, DeepLife, Melt&Marble, Vincere Biosciences, Cellvie, S-Biomedic, Salvalco, and Dermanostic. |
See public comps similar to Beiersdorf
Lists including Beiersdorf
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


